Abstract
Allergic rhinitis (AR) is one of the most common diseases and represents a global health problem, currently affecting up to 30% of the general population, with a continuously increasing prevalence and significant comorbidities and complications. The aim of this review is to provide an update on AR treatment, with a focus on current therapies defined by AR and its impact on asthma guidelines and with a particular emphasis on new and future therapeutic perspectives.
| Original language | English |
|---|---|
| Pages (from-to) | 1337-1347 |
| Number of pages | 11 |
| Journal | Expert Review of Clinical Immunology |
| Volume | 10 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Oct 1 2014 |
Fingerprint
Keywords
- allergic rhinitis
- drugs
- efficacy
- immunology
- inflammation
- safety
- therapy
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Cite this
Current recommendations and emerging options for the treatment of allergic rhinitis. / Licari, Amelia; Ciprandi, Giorgio; Marseglia, Alessia; Castagnoli, Riccardo; Barberi, Salvatore; Caimmi, Silvia; Marseglia, Gian Luigi.
In: Expert Review of Clinical Immunology, Vol. 10, No. 10, 01.10.2014, p. 1337-1347.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Current recommendations and emerging options for the treatment of allergic rhinitis
AU - Licari, Amelia
AU - Ciprandi, Giorgio
AU - Marseglia, Alessia
AU - Castagnoli, Riccardo
AU - Barberi, Salvatore
AU - Caimmi, Silvia
AU - Marseglia, Gian Luigi
PY - 2014/10/1
Y1 - 2014/10/1
N2 - Allergic rhinitis (AR) is one of the most common diseases and represents a global health problem, currently affecting up to 30% of the general population, with a continuously increasing prevalence and significant comorbidities and complications. The aim of this review is to provide an update on AR treatment, with a focus on current therapies defined by AR and its impact on asthma guidelines and with a particular emphasis on new and future therapeutic perspectives.
AB - Allergic rhinitis (AR) is one of the most common diseases and represents a global health problem, currently affecting up to 30% of the general population, with a continuously increasing prevalence and significant comorbidities and complications. The aim of this review is to provide an update on AR treatment, with a focus on current therapies defined by AR and its impact on asthma guidelines and with a particular emphasis on new and future therapeutic perspectives.
KW - allergic rhinitis
KW - drugs
KW - efficacy
KW - immunology
KW - inflammation
KW - safety
KW - therapy
UR - http://www.scopus.com/inward/record.url?scp=84907278919&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84907278919&partnerID=8YFLogxK
U2 - 10.1586/1744666X.2014.955476
DO - 10.1586/1744666X.2014.955476
M3 - Article
C2 - 25225773
AN - SCOPUS:84907278919
VL - 10
SP - 1337
EP - 1347
JO - Expert Review of Clinical Immunology
JF - Expert Review of Clinical Immunology
SN - 1744-666X
IS - 10
ER -